T-Cell Proliferation of Uncertain Malignant Potential — knowledge graph · CancerIndex

Knowledge graph · Cancer

T-Cell Proliferation of Uncertain Malignant Potential

hematologic malignancy

Identifier: CI-CAN-00000361
Entity page: /cancer/t-cell-proliferation-of-uncertain-malignant-potential ↗
Edges: 11

Neighbours: 4 drugs7 trials
Drawn: 11 of 11 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
T-Cell Proliferation of Uncertain Malignant Potential investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Brentuximab Vedotinadc 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	T-Cell Proliferation of Uncertain Malignant Potential	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall molecule

T-Cell Proliferation of Uncertain Malignant Potential studied in …STUDIED_INderived7 of 7
→ studied in	NCT03409432Phase 2 · completed Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01352520Phase 2 · active not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT06207812recruiting Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT03587844Phase 2 · recruiting Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT02840747recruiting Tissue Repository: CTCL Collection Protocol · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05106192NA · withdrawn Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. · condition mapped ONTOLOGY_EXACT · 7 trials mapped (5 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →